C
CPIX
Cumberland Pharmaceuticals Inc
3.17
0.07+2.26%After Hours: 3.170 0.00 0.00%16:10 04/02 EDT
OPEN/PREV CLOSE3.090/3.100
TODAY RANGE3.000-3.225
VOL80.98K
MARKET CAP47.41M
52 WEEK RANGE1.850-6.27
AVG VOL (3M)158.42K
% TURNOVER0.54%
TURNOVER--
P/E (TTM)-16.6056
% RANGE7.26%
EPS(TTM)-0.1909
P/E(FORWARD)37.43
P/B1.906
BVPS1.664
DIVIDEND--
P/S1.065
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP26.57M
SHARES OUTSTANDING14.96M
NEXT EARNINGS05/04-05/08
FREE FLOAT8.38M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·03/17 13:21
Cumberland announces launch of new Sancuso website
NASDAQ·03/10 17:49
Cumberland Q4 Loss Narrows Y/Y as Talicia Launch Boosts Sales
Reuters·03/09 21:03
Cumberland Pharmaceuticals Inc. Announces Annual Shareholder Meeting
Press release·03/09 14:21
Form 10-K: Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Seeking Alpha·03/04 00:33
Cumberland targets double-digit revenue growth in 2026 as Talicia and Vibativ fuel expansion
NASDAQ·03/03 22:45
Cumberland (CPIX) Q4 2025 Earnings Call Transcript
Reuters·03/03 22:12
Cumberland Pharmaceuticals 2025 revenue rises
Seeking Alpha·03/03 22:11
Cumberland Pharmaceuticals Non-GAAP EPS of $0.11, revenue of $44.5M
Dow Jones·03/03 22:01
*CUMBERLAND PHARMACEUTICALS REPORTS 31% 4Q 2025 Rev GROWTH
Dow Jones·03/03 22:01
*Cumberland Pharma 4Q Rev $13.7M >CPIX
Reuters·03/03 22:00
CUMBERLAND PHARMACEUTICALS REPORTS 31% FOURTH QUARTER 2025 REVENUE GROWTH
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.